These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4621612)

  • 1. Observations on the action of rifampin and ethambutol alone and in combination with other antituberculous drugs.
    Hobby GL; Lenert TF
    Am Rev Respir Dis; 1972 Feb; 105(2):292-5. PubMed ID: 4621612
    [No Abstract]   [Full Text] [Related]  

  • 2. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
    Dickinson JM; Aber VR; Mitchison DA
    Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity to rifampicin and ethambutol of mycobacteria resistant to isoniazid or streptomycin].
    Golychevskaja VI
    G Ital Chemioter; 1972; 19(2):20-2. PubMed ID: 4199029
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 5. E-test: an alternative method for susceptibility testing of Mycobacterium tuberculosis.
    Akcali S; Cicek C; Surucuoglu S; Ozbakkaloglu B
    Med Princ Pract; 2005; 14(4):264-7. PubMed ID: 15961938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol.
    Hobby GL; Johnson PM; Boytar-Papirnyik V; Wilber J
    Am Rev Respir Dis; 1969 May; 99(5):777-9. PubMed ID: 4978401
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth inhibition of tubercle bacilli after pulsed exposures to combinations of antituberculous drugs.
    Beggs WH
    Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):487-90. PubMed ID: 807961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
    Golyshevskaia VI; El'shanskaia MP
    Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
    Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
    Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of the action of drugs in the short-course chemotherapy].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):36-40. PubMed ID: 2416374
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.
    Dickinson JM; Mitchison DA
    Tidsskr Nor Laegeforen; 1975 Jun; 95(17-18):1087-9. PubMed ID: 806991
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-resistant Mycobacterium tuberculosis in Korean isolates.
    Carpenter JL; Covelli HD; Avant ME; McAllister CK; Higbee JW; Ognibene AJ
    Am Rev Respir Dis; 1982 Dec; 126(6):1092-5. PubMed ID: 6185025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary resistance of Mycobacterium tuberculosis in the province of Vizcaya].
    Echeverría MJ; Ayarza R; Jiménez MS; López de Goicoechea MJ; Berdonces P; Ibarretxebea AB
    Rev Esp Quimioter; 1999 Jun; 12(2):152-3. PubMed ID: 10562678
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
    Elghoul MT; Joshi RM; Rizghalla T
    Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change in drug resistance of Mycobacterium tuberculosis in experimental studies].
    Dushkevich AK; Bartashevich TA
    Probl Tuberk; 1974; (11):78-82. PubMed ID: 4217456
    [No Abstract]   [Full Text] [Related]  

  • 16. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug susceptibility in Mycobacterium tuberculosis of a sample of patients in Guinea Bissau.
    Dias F; Michael SG; Hoffner SE; Martins L; Norberg R; Källenius G
    Tuber Lung Dis; 1993 Apr; 74(2):129-30. PubMed ID: 8324205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanisms of drug resistance of Mycobacterium tuberculosis].
    Stepanshin IuG; Stepanshina VN; Shemiakin IG
    Antibiot Khimioter; 1999; 44(4):39-43. PubMed ID: 10483496
    [No Abstract]   [Full Text] [Related]  

  • 19. Mode of action of antituberculous drugs and mechanisms of drug resistance in Mycobacterium tuberculosis.
    Rastogi N; David HL
    Res Microbiol; 1993 Feb; 144(2):133-43. PubMed ID: 8337471
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.
    Kothadia SN; Sengupta SR
    Indian J Chest Dis Allied Sci; 1984; 26(3):163-6. PubMed ID: 6443608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.